The data, presented in a poster titled "AP402, a bispecific antibody targeting p95HER2 and CD137, shows potent antitumor activity," highlight the therapeutic potential of AP402 to address ...

FYR, a biotechnology company leveraging extracellular vesicles (EVs) to dynamically observe disease and treatment responses, today announced a collaboration with Mayo Clinic seeking to advance the use ...

Digital Utilities Ventures (OTC: DUTV) is evolving into Easy Environmental Solutions, Inc., to better reflect its focus on environmental sustainability. The company will continue to advance ...

DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will ...

The current publication, “ Four-year follow-up from a prospective, multicenter study of percutaneous 60-day peripheral nerve stimulation for chronic low back pain ” appears in Pain and Therapy and the ...

STUDIO CITY, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime ...

Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025. Annamycin is potentially a highly versatile drug capable of working synergistically with ...

Dr. Lalezari will be joined at the conference by Dr. Richard Pestell, MD, PhD, AO, Lead Consultant in Preclinical and Clinical Oncology, who will present during the poster display session in Hall B0 ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, presented noteworthy new data at the American Association for ...

In 2024, the Centers for Medicare & Medicaid Services (“CMS”) finalized a Medicare reimbursement pathway for personal exoskeleton use, which further expanded access to the ReWalk Exoskeleton for ...

Voom Medical Devices, Inc. (“Voom” or “the Company”), a leader in minimally invasive orthopedic solutions, today announced the successful closing of a $30 million capital raise through a combination ...

About EDX Medical Group EDX Medical Group plc is headquartered in Cambridge, UK, and is listed on the Apex Segment of the AQSE Growth Market (TIDM: EDX). EDX Medical was founded by Professor Sir ...